Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, No. 8, Nanhu Ave., Hongshan District, Wuhan 430064, China.
Institute of Infection, Immunology and Tumor Microenvironment, Institute of Pharmaceutical Process, Department of Pharmacy, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, No. 2, Huangjiahu East Road, Hongshan District, Wuhan 430081, China.
Molecules. 2023 Jan 15;28(2):878. doi: 10.3390/molecules28020878.
Pseudorabies virus (PRV) is a pathogen that causes Aujeszky's disease (AD) in animals, leading to huge economic losses to swine farms. In order to discover anti-PRV compounds, we studied the extracts of the strain NBERC-24992, which showed significant anti-PRV activity. Eight benzoheterocyclic secondary metabolites, including three new compounds (-, virantmycins D-G) and five known compounds (-, virantmycin, A-503451 D, A-503451 D acetylate, A-503451 A, and A-503451 B), were isolated from the broth of NBERC-24992. The structures of the new compounds were identified by using extensive spectroscopic data, including mass spectrometry (MS), nuclear magnetic resonance (NMR), and electronic circular dichroism (ECD). Compound was found to be a novel heterocyclic compound with a tricyclic skeleton from natural product. All compounds were tested for antiviral activity, and (virantmycin) showed an excellent effect against PRV and was better than ribavirin and acyclovir. Our study revealed that chlorine atom and tetrahydroquinoline skeleton were important active moiety for antiviral activity. Virantmycin could be a suitable leading compound for an antiviral drug against PRV.
伪狂犬病毒(PRV)是一种病原体,可导致动物发生伪狂犬病(AD),给养猪场造成巨大的经济损失。为了发现抗 PRV 化合物,我们研究了表现出显著抗 PRV 活性的 NBERC-24992 株的提取物。从 NBERC-24992 的发酵液中分离出了 8 种苯并杂环类次生物质,包括 3 种新化合物(-, virantmycins D-G)和 5 种已知化合物(-, virantmycin, A-503451 D, A-503451 D 乙酰化,A-503451 A 和 A-503451 B)。新化合物的结构通过广泛的光谱数据(包括质谱(MS)、核磁共振(NMR)和电子圆二色性(ECD))确定。化合物 是一种从天然产物中发现的具有三环骨架的新型杂环化合物。所有化合物均进行了抗病毒活性测试,结果表明 (virantmycin)对 PRV 具有极好的抑制效果,优于利巴韦林和阿昔洛韦。我们的研究表明,氯原子和四氢喹啉骨架是抗病毒活性的重要活性部分。Virantmycin 可能是一种针对 PRV 的抗病毒药物的合适先导化合物。